Exodus Point Capital Management, LP Agios Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

$14.7 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$21.32 - $34.81 $2.17 Million - $3.54 Million	101,612 New	101,612 $2.97 Million
Q2 2023 Aug 10, 2023	SELL	$21.38 - $29.19 $1.67 Million - $2.28 Million	-78,003 Reduced 39.32%	120,363 $3.41 Million
Q1 2023 May 11, 2023	BUY	$21.74 - $30.93 $4.01 Million - $5.7 Million	184,341 Added 1314.37%	198,366 $4.56 Million
Q4 2022 Feb 13, 2023	BUY	$24.81 - $31.52 $347,960 - $442,068	14,025 New	14,025 $394,000
Q3 2022 Nov 10, 2022	SELL	$19.51 - $34.14 $1.18 Million - $2.06 Million	-60,238 Closed	0 $0
Q2 2022 Aug 19, 2022	SELL	$17.06 - $31.42 $1.81 Million - $3.34 Million	-106,221 Reduced 63.81%	60,238 $1.34 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $34.81 $4.14 Million - $5.41 Million	155,287 Added 1389.97%	166,459 $4.85 Million
Q4 2021 Feb 11, 2022	SELL	$29.58 - $49.78 $408,381 - $687,262	-13,806 Reduced 55.27%	11,172 $367,000
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $880,990 - $1.22 Million	21,016 Added 530.44%	24,978 $1.15 Million
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $3.37 Million - $3.96 Million	-64,711 Reduced 94.23%	3,962 $218,000
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $129,505 - $168,360	-2,928 Reduced 4.09%	68,673 $3.55 Million
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $1.39 Million - $1.95 Million	41,829 Added 140.5%	71,601 $3.1 Million
Q3 2020 Nov 16, 2020	SELL	$33.87 - $55.93 $1.02 Million - $1.69 Million	-30,136 Reduced 50.3%	29,772 $1.04 Million
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $2.06 Million - $3.2 Million	59,908 New	59,908 $3.2 Million
Q2 2019 Aug 14, 2019	SELL	$46.17 - $68.1 $582,711 - $859,490	-12,621 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $579,556 - $854,063	12,621 New	12,621 $851,000

Others Institutions Holding AGIO

# of Institutions

226

Shares Held

56.3M

Call Options Held

275K

Put Options Held

251K

Farallon Capital Management LLC San Francisco, CA

5.65M
Shares

$251 Million
1.18% of portfolio
Vanguard Group Inc Valley Forge, PA

5.5M
Shares

$244 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$216 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.88M
Shares

$172 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.78M
Shares

$123 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.44B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account